SCHEMBL9019276

SCHEMBL9019276

Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)[C@H](CCS(C)(=O)=O)NN2CCC(C(=O)OC(C)(C)C)CC2)C3(C)C)CC1

nearest known ligand 0.76

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
OXTR P30559 5/20 0.76
AVPR2 P30518 2/20 0.76
AVPR1A P37288 2/20 0.76
AVPR1B P47901 1/20 0.76
CYP3A4 P08684 1/20 0.71
TSHR P16473 1/20 0.71
MEN1 O00255 1/20 0.71
BLM P54132 1/20 0.71
PMP22 Q01453 1/20 0.71
KMT2A Q03164 1/20 0.71
OPRK1 P41145 1/20 0.71
TMEM97 Q5BJF2 1/20 0.71
SIGMAR1 Q99720 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7286362 0.89 OXTR (0.81) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7315105 0.89 OXTR (0.81) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL8846557 0.87 OXTR (0.77) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7302900 0.87 OXTR (1.00) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7304643 0.86 OXTR (0.82) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7313655 0.85 OXTR (0.86) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7310796 0.85 OXTR (0.86) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7308336 0.85 OXTR (0.86) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7302934 0.85 OXTR (0.76) OXTRAVPR2AVPR1AAVPR1BCYP3A4
SCHEMBL7307014 0.85 OXTR (0.85) OXTRAVPR2AVPR1AAVPR1BCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0708765-A4 SUBSTITUTED PIPERAZINYLCAMPHOR DERIVATIVES AS OXYTOCIN ANTAGONISTS MERCK & CO INC (US) 1996-06-26 EP disclosed
EP-0708765-A1 SUBSTITUTED PIPERAZINYLCAMPHOR DERIVATIVES AS OXYTOCIN ANTAGONISTS MERCK & CO. INC. (US) 1996-05-01 EP disclosed